LifeVantage to Announce First Quarter Fiscal Year 2026 Results on November 4, 2025 GlobeNewswire October 21, 2025 SALT LAKE CITY, Oct. 21, 2025 (GLOBE NEWSWIRE) — LifeVantage Corporation (Nasdaq:LFVN) a leading health and wellness company with products designed to activate optimal health processes at the cellular level, today announced that it will release financial results […]
Ceribell to Report Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 SUNNYVALE, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — CeriBell, Inc. (Nasdaq: CBLL) (“Ceribell”), a medical technology company focused on transforming the diagnosis and management of patients with serious neurological conditions, today announced that it will release financial results for
Xometry to Announce Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 NORTH BETHESDA, Md., Oct. 21, 2025 (GLOBE NEWSWIRE) — Xometry, Inc. (NASDAQ: XMTR), the global AI-powered marketplace connecting buyers and suppliers of custom manufacturing, announced it will report its third quarter 2025 financial results before the market opens on
Beyond Meat(R) to Report Third Quarter 2025 Financial Results on November 4, 2025 GlobeNewswire October 21, 2025 EL SEGUNDO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Beyond Meat, Inc. (NASDAQ: BYND) (“Beyond Meat” or “the Company”), a leader in plant-based meat, announced today it will report financial results for the third quarter ended September 27,
Remitly to Report Third Quarter Financial Results on November 5, 2025 GlobeNewswire October 21, 2025 SEATTLE, Oct. 21, 2025 (GLOBE NEWSWIRE) — Remitly Global, Inc. (NASDAQ: RELY) (“Remitly”), a trusted provider of digital financial services that transcend borders, today announced that it will report third quarter financial results after the market close on Wednesday, November
InspireMD to Announce Third Quarter 2025 Financial Results GlobeNewswire October 21, 2025 MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) — InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard(R) Prime carotid stent system for the prevention of stroke, today announced that it will release its third quarter 2025 financial results on Tuesday, November 4, 2025. In conjunction
Alector Announces Topline Results from Latozinemab Phase 3 Trial in Individuals with Frontotemporal Dementia Due to a GRN Mutation and Provides Business Update GlobeNewswire October 21, 2025 SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) — Alector, Inc. (Nasdaq: ALEC), a clinical-stage biotechnology company focused on developing therapies to counteract the devastating progression of
Synchronoss Technologies Announces Third Quarter 2025 Earnings Call Date GlobeNewswire October 21, 2025 BRIDGEWATER, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) — Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in Personal Cloud platforms, will hold a conference call on Tuesday, November 4, 2025 at 4:30 p.m. Eastern time (1:30
(NASDAQ:MCRI), The 2025 Third Quarter Marks the Highest-Ever Quarterly Level of Revenue, Net Income and EBITDA in Company's 32 Year History Declares Cash Dividend of $0.30 per Share Payable on December 15, 2025 RENO, Nev., Oct. 21, 2025 (GLOBE NEWSWIRE) — Monarch Casino & Resort, Inc. (Nasdaq: MCRI) (“Monarch” or “the Company”) today reported operating
(TSX-V:NRX),(Frankfurt:J90),(Boerse Stuttgart – Freiverkehr:J90),(Boerse Muenchen – Freiverkehr:J90),(OTC US:NRXBF),(Other OTC:NRXBF), TORONTO and HAIFA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) — NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”) a biopharmaceutical company developing exosome-based regenerative therapies, announced that Dr. Ina Sarel, Director of Clinical and Regulatory Affairs, has been invited to speak